1. Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response. Issue 2 (February 2021) Authors: Chiloiro, Sabrina; Giampietro, Antonella; Mirra, Federica; Donfrancesco, Federico; Tartaglione, Tommaso; Mattogno, Pier Paolo; Angelini, Flavia; Liverana, Lauretti; Gessi, Marco; Carmelo, Anile; Rindi, Guido; Giustina, Andrea; Fleseriu, Maria; Pontecorvi, Alfredo; De Marinis, Laura; Bianchi, Antonio Journal: European journal of endocrinology Issue: Volume 184:Issue 2(2021) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗